{"id":47163,"date":"2026-07-21T09:01:27","date_gmt":"2026-07-21T00:01:27","guid":{"rendered":"https:\/\/blog.agentsoft.co.kr\/index.php\/2026\/07\/21\/47163\/"},"modified":"2026-07-21T09:01:27","modified_gmt":"2026-07-21T00:01:27","slug":"%ec%84%b1%ec%9d%b8%ea%b0%84%ed%98%b8%ed%95%99-%eb%87%8c%ea%b2%bd%ec%83%89-%ec%bc%80%ec%9d%b4%ec%8a%a4-%ec%8a%a4%ed%84%b0%eb%94%94-%ec%a7%84%eb%8b%a83%ea%b0%9c-%ea%b0%84%ed%98%b8%ea%b3%bc%ec%a0%953","status":"publish","type":"post","link":"https:\/\/blog.agentsoft.co.kr\/index.php\/2026\/07\/21\/47163\/","title":{"rendered":"[\uc131\uc778\uac04\ud638\ud559] \ub1cc\uacbd\uc0c9 \ucf00\uc774\uc2a4 \uc2a4\ud130\ub514 \uc9c4\ub2e83\uac1c, \uac04\ud638\uacfc\uc8153\uac1c(\uc9c4\ub2e8\uc801\/\uce58\ub8cc\uc801\/\uad50\uc721\uc801 \uad6c\ubd84)"},"content":{"rendered":"

<\/p>\n

\ubaa9\ucc28<\/strong><\/p>\n

1. \uac04\ud638\ub825
\n2. \uc9c8\ubcd1\uc758 \uae30\uc220
\n3. \uc2e0\uccb4\uac80\uc9c4
\n4. \uc785\uc6d0 \uc911 \ucc98\uce58
\n5. \uc9c4\ub2e8\uac80\uc0ac
\n6. \uc785\uc6d0 \ud6c4 \uacbd\uacfc
\n7. \uac04\ud638\uacfc\uc815<\/p>\n

\ubcf8\ubb38\ub0b4\uc6a9<\/strong><\/p>\n

1) \uac04\ud638\ub825
\n(1) \uc77c\ubc18\uc801 \uc0ac\ud56d
\n– \ubcd1\ub3d9: (11\/8 18\uc2dc \uc804\ub3d9)
\n– \uc131\ud568: \uc815OO
\n– \uc131\ubcc4\/\uc5f0\ub839: F\/85
\n– \uc785\uc6d0 \ub0a0\uc9dc: 2023.11.7. 9\uc2dc (11\/10 \uae30\uc900 HOD4)
\n– \ud1f4\uc6d0 \ub0a0\uc9dc: 2023.11.10. 14\uc2dc
\n– \uac04\ud638 \uc218\ud589 \uae30\uac04: 2023.11.7. ~ 2023.11.10.
\n– \uc785\uc6d0 \ub3d9\uae30: 11\uc6d4 6\uc77c 18\uc2dc, \ud654\uc7a5\uc2e4\uc744 \uac00\ub824\ub2e4 Lt side weakness \ubc1c\uc0dd\ud558\uc5ec
\n11\uc6d4 7\uc77c \uc624\uc804 8\uc2dc \ubcf4\ud638\uc790\uc5d0 \uc758\ud574 \ubc1c\uacac, \uc624\uc804 9\uc2dc \uc751\uae09\uc2e4 \ub0b4\uc6d0\ud558\uc5ec CI (PACI MCA Rt) \uc9c4\ub2e8 \ud6c4 SU \uc785\uc2e4
\n– \uc9c4\ub2e8\uba85: [\uc8fc] Cerebral infacrtion due to unspecified occlusion or stenosis of middle cerebral artery
\n\uc911\ub300\ub1cc\ub3d9\ub9e5\uc758 \uc0c1\uc138\ubd88\uba85 \ud3d0\uc1c4 \ub610\ub294 \ud611\ucc29\uc5d0 \uc758\ud55c \ub1cc\uacbd\uc0c9\uc99d
\n(2) \uc8fc\ud638\uc18c : Lt limb weakness
\n(3) \ud604\ubcd1\ub825
\nO onset 2023\ub144 11\uc6d4 6\uc77c 18\uc2dc
\nL location Lt side limb
\nD duration 11\/6 \uc774\ud6c4\ub85c \uc9c0\uc18d
\nC characteristics
\n\uc67c\ucabd \ud314\uacfc \ub2e4\ub9ac\uc5d0 \ud798\uc774 \uc548 \ub4e4\uc5b4\uac00\uace0, \uc628\ubab8\uc5d0 \uae30\uc6b4\uc774 \uc5c6\uc774 \uccd0\uc9c4\ub2e4
\n\ud314\ub2e4\ub9ac\ub97c \ub9cc\uc838\ub3c4 \uac10\uac01\uc774 \uc798 \uc548 \ub290\uaef4\uc9c4\ub2e4
\nA
\naggravating factors –
\nalleviating factors –
\nR related symptom
\n– Lt facial palsy(2)
\n– Lt side neglect(2)-\ubcf8\uc778 \ud314\uc784\uc744 \uc778\uc9c0\ud568
\n– Lt side 50% \uc774\uc0c1 \uac10\uac01 \uc800\ud558(\uaf2c\uc9d1\uc5b4\uc57c \ub290\uaef4\uc9c0\ub294 \uac10\uac01\uc800\ud558), tactile \uc788\uc74c
\n– dysarthria (dysarthria \uc788\ub294 \uac83 \uac19\uc73c\ub098 \ubcf4\ud638\uc790 \uc9c4\uc220\uc0c1, \ud2c0\ub2c8\ub97c \ub07c\uc9c0 \uc54a\uc544 \uadf8\ub7f0 \uac83\uc774\ub77c \ud568)
\n– 11\/8 15\uc2dc \uc591\uce21 \ub2e4\ub9ac \ud1b5\uc99d(NRS 4\uc810) -> AAP(16\uc2dc NRS 0\uc810)
\nT treatment \uc57d\ubb3c \uc911\uc7ac aspirin, clopidogrel, rosuvastatin
\nS severity NIHSS 11\/7 9\uc810 -> 11\/8 7\uc810, Motor Power 11\/7~ LA \u2163 – LL \u2163<\/p>\n

\ucd9c\ucc98 : \ud574\ud53c\ucea0\ud37c\uc2a4<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

\ubaa9\ucc28 1. \uac04\ud638\ub825 2. \uc9c8\ubcd1\uc758 \uae30\uc220 3. \uc2e0\uccb4\uac80\uc9c4 4. \uc785\uc6d0 \uc911 \ucc98\uce58 5. \uc9c4\ub2e8\uac80\uc0ac 6. \uc785\uc6d0 \ud6c4 \uacbd\uacfc 7. \uac04\ud638\uacfc\uc815 \ubcf8\ubb38\ub0b4\uc6a9 1) \uac04\ud638\ub825 (1) \uc77c\ubc18\uc801 \uc0ac\ud56d – \ubcd1\ub3d9: (11\/8 18\uc2dc \uc804\ub3d9) – \uc131\ud568: \uc815OO – \uc131\ubcc4\/\uc5f0\ub839: F\/85 – \uc785\uc6d0 \ub0a0\uc9dc: 2023.11.7. 9\uc2dc (11\/10 \uae30\uc900 HOD4) – \ud1f4\uc6d0 \ub0a0\uc9dc: 2023.11.10. 14\uc2dc – \uac04\ud638 \uc218\ud589 \uae30\uac04: 2023.11.7. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[9301,23958,53434,46966],"class_list":["post-47163","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-__aa","tag-23958","tag-a--","tag-46966"],"_links":{"self":[{"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/posts\/47163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/comments?post=47163"}],"version-history":[{"count":0,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/posts\/47163\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/media?parent=47163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/categories?post=47163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/tags?post=47163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}